{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:39:39Z","timestamp":1790962779934,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Department of Biotechnology, Government of India, India","award":["BT\/PR26420\/MED\/12\/774\/2017"],"award-info":[{"award-number":["BT\/PR26420\/MED\/12\/774\/2017"]}]},{"name":"Department of Biotechnology, Government of India, India","award":["BT\/PR26420\/MED\/12\/774\/2017"],"award-info":[{"award-number":["BT\/PR26420\/MED\/12\/774\/2017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-79516-7","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T01:25:31Z","timestamp":1731720331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A series of genetically confirmed congenital lipodystrophy and diabetes in adult southern Indian patients"],"prefix":"10.1038","volume":"14","author":[{"given":"Remya","family":"Rajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Chapla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jabasteen","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deny","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. S.","family":"Asha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Jebasingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas V.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"issue":"1","key":"79516_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.genom.7.080505.115715","volume":"7","author":"AK Agarwal","year":"2006","unstructured":"Agarwal, A. K. & Garg, A. Genetic disorders of adipose tissue development, differentiation, and death. Annu. Rev. Genom Hum. Genet. 7 (1), 175\u2013199 (2006).","journal-title":"Annu. Rev. Genom Hum. Genet."},{"issue":"2","key":"79516_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2337\/db19-0447","volume":"69","author":"C Gonzaga-Jauregui","year":"2019","unstructured":"Gonzaga-Jauregui, C. et al. Clinical and molecular prevalence of Lipodystrophy in an unascertained large clinical care cohort. Diabetes. 69 (2), 249\u2013258 (2019).","journal-title":"Diabetes"},{"issue":"10","key":"79516_CR3","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1210\/jc.2003-030855","volume":"88","author":"AK Agarwal","year":"2003","unstructured":"Agarwal, A. K. et al. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J. Clin. Endocrinol. Metab. 88 (10), 4840\u20134847 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"79516_CR4","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1210\/clinem\/dgac079","volume":"107","author":"LT Fourman","year":"2022","unstructured":"Fourman, L. T. & Grinspoon, S. K. Approach to the patient with Lipodystrophy. J. Clin. Endocrinol. Metabolism. 107 (6), 1714\u20131726 (2022).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"4","key":"79516_CR5","doi-asserted-by":"publisher","first-page":"e142245","DOI":"10.1172\/JCI142245","volume":"131","author":"AM Angelidi","year":"2021","unstructured":"Angelidi, A. M., Filippaios, A. & Mantzoros, C. S. Severe insulin resistance syndromes. J. Clin. Invest. 131 (4), e142245 (2021).","journal-title":"J. Clin. Invest."},{"issue":"12","key":"79516_CR6","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1210\/jc.2016-2466","volume":"101","author":"RJ Brown","year":"2016","unstructured":"Brown, R. J. et al. The diagnosis and management of Lipodystrophy syndromes: a Multi-society Practice Guideline. J. Clin. Endocrinol. Metabolism. 101 (12), 4500\u20134511 (2016).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"1","key":"79516_CR7","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.4158\/EP14346.CR","volume":"1","author":"HS Asha","year":"2015","unstructured":"Asha, H. S., Chapla, A., Shetty, S. & Thomas, N. Next-generation sequencing-based genetic testing for familial partial lipodystrophy. AACE Clin. Case Rep. 1 (1), e28\u201331 (2015).","journal-title":"AACE Clin. Case Rep."},{"issue":"10","key":"79516_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13312-019-1617-0","volume":"56","author":"R Joshi","year":"2019","unstructured":"Joshi, R. & Sharma, S. Berardinelli Seip congenital lipodystrophy syndrome: 10 year follow-up. Indian Pediatr. 56 (10), 877\u2013878 (2019).","journal-title":"Indian Pediatr."},{"issue":"5","key":"79516_CR9","first-page":"440","volume":"43","author":"K Mandal","year":"2006","unstructured":"Mandal, K., Aneja, S., Seth, A. & Khan, A. Berardinelli-Seip congenital lipodystrophy. Indian Pediatr. 43 (5), 440\u2013445 (2006).","journal-title":"Indian Pediatr."},{"issue":"4","key":"79516_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.4158\/EP10396.VV","volume":"17","author":"S Kannan","year":"2011","unstructured":"Kannan, S., Khanna, I., Kaur, M. & Radin, M. Visual vignette. Type 2 familial partial lipodystrophy syndrome of the Dunnigan variety. Endocr. Pract. 17 (4), 665 (2011).","journal-title":"Endocr. Pract."},{"key":"79516_CR11","doi-asserted-by":"publisher","first-page":"bcr2016214493","DOI":"10.1136\/bcr-2016-214493","volume":"2016","author":"PP Chakraborty","year":"2016","unstructured":"Chakraborty, P. P., Datta, S., Mukhopadhyay, S. & Chowdhury, S. Pseudoacromegaly in congenital generalised lipodystrophy (Berardinelli-Seip syndrome). BMJ Case Rep. 2016, bcr2016214493 (2016).","journal-title":"BMJ Case Rep."},{"issue":"6","key":"79516_CR12","first-page":"164","volume":"9","author":"S Shetty","year":"2016","unstructured":"Shetty, S., Chapla, A., Kapoor, N., Thomas, N. & Paul, T. V. A novel variant of the AGPAT2 mutation in generalized congenital lipodystrophy, detected by next generation sequencing. Australas Med. J. (Online). 9 (6), 164 (2016).","journal-title":"Australas Med. J. (Online)"},{"issue":"1","key":"79516_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jocd.2013.01.002","volume":"17","author":"RK Marwaha","year":"2014","unstructured":"Marwaha, R. K. et al. Normative data of body fat mass and its distribution as assessed by DXA in Indian adult population. J. Clin. Densitom. 17 (1), 136\u2013142 (2014).","journal-title":"J. Clin. Densitom"},{"issue":"5","key":"79516_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17 (5), 405\u2013424 (2015).","journal-title":"Genet. Med."},{"issue":"4","key":"79516_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/cen.12541","volume":"82","author":"A Chapla","year":"2015","unstructured":"Chapla, A. et al. Maturity onset diabetes of the young in India\u2013a distinctive mutation pattern identified through targeted next-generation sequencing. Clin. Endocrinol. 82 (4), 533\u2013542 (2015).","journal-title":"Clin. Endocrinol."},{"key":"79516_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fendo.2020.00039","volume":"11","author":"G Ceccarini","year":"2020","unstructured":"Ceccarini, G. et al. Congenital generalized lipoatrophy (Berardinelli-Seip syndrome) type 1: description of novel AGPAT2 homozygous variants showing the highly heterogeneous presentation of the disease. Front. Endocrinol. 11, 39 (2020).","journal-title":"Front. Endocrinol."},{"issue":"5","key":"79516_CR17","first-page":"559","volume":"64","author":"AD Costa-Riquetto","year":"2021","unstructured":"Costa-Riquetto, A. D. et al. Targeted massively parallel sequencing for congenital generalized lipodystrophy. Arch. Endocrinol. Metab. 64 (5), 559\u2013566 (2021).","journal-title":"Arch. Endocrinol. Metab."},{"issue":"5","key":"79516_CR18","first-page":"1776","volume":"85","author":"A Garg","year":"2000","unstructured":"Garg, A. Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J. Clin. Endocrinol. Metab. 85 (5), 1776\u20131782 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"79516_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/cen.13984","volume":"91","author":"ATP Resende","year":"2019","unstructured":"Resende, A. T. P. et al. Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2. Clin. Endocrinol. (Oxf). 91 (1), 94\u2013103 (2019).","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"4","key":"79516_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/0026-0495(85)90222-7","volume":"34","author":"MP Golden","year":"1985","unstructured":"Golden, M. P. et al. Insulin resistance in total lipodystrophy: evidence for a pre-receptor defect in insulin action. Metabolism. 34 (4), 330\u2013335 (1985).","journal-title":"Metabolism"},{"key":"79516_CR21","first-page":"20","volume":"2021","author":"C Chaves","year":"2021","unstructured":"Chaves, C., Chaves, M., Anselmo, J. & C\u00e9sar, R. Successful long-term use of pioglitazone in Berardinelli\u2013Seip lipodystrophy-associated diabetes. Endocrinol. Diabetes Metab. Case Rep. 2021, 20\u20130183 (2021).","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"issue":"5","key":"79516_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.diabet.2007.04.005","volume":"33","author":"F Moreau","year":"2007","unstructured":"Moreau, F. et al. Efficacy of pioglitazone in familial partial lipodystrophy of the Dunnigan type: a case report. Diabetes Metab. 33 (5), 385\u2013389 (2007).","journal-title":"Diabetes Metab."},{"issue":"1","key":"79516_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1507\/endocrj.EJ22-0140","volume":"70","author":"T Iizaka","year":"2023","unstructured":"Iizaka, T. et al. Clinical characteristics and efficacy of pioglitazone in a Japanese patient with familial partial lipodystrophy due to peroxisome proliferator-activated receptor \u03b3 gene mutation. Endocr. J. 70 (1), 69\u201376 (2023).","journal-title":"Endocr. J."},{"issue":"6","key":"79516_CR24","doi-asserted-by":"publisher","first-page":"656","DOI":"10.4158\/EP.13.6.656","volume":"13","author":"GG Sleilati","year":"2007","unstructured":"Sleilati, G. G., Leff, T., Bonnett, J. W. & Hegele, R. A. Efficacy and safety of pioglitazone in treatment of a patient with an atypical partial lipodystrophy syndrome. Endocr. Pract. 13 (6), 656\u2013661 (2007).","journal-title":"Endocr. Pract."},{"issue":"6","key":"79516_CR25","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.2337\/db17-1236","volume":"67","author":"M Agostini","year":"2018","unstructured":"Agostini, M. et al. A Pharmacogenetic Approach to the treatment of patients with PPARG mutations. Diabetes. 67 (6), 1086\u20131092 (2018).","journal-title":"Diabetes"},{"key":"79516_CR26","doi-asserted-by":"crossref","unstructured":"Simha, V., Rao, S. & Garg, A. Prolonged thiazolidinedione therapy does not reverse fat loss in patients with familial partial lipodystrophy, Dunnigan variety: Letter to the Editor. Diabetes, Obesity and Metabolism. ;10(12):1275\u20136. (2008).","DOI":"10.1111\/j.1463-1326.2008.00978.x"},{"issue":"4","key":"79516_CR27","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.18203\/2349-3933.ijam20173225","volume":"4","author":"HS Deep","year":"2017","unstructured":"Deep, H. S., Singh, B. P. & Singh, S. P. Evaluation of serum c-peptide levels in type 2 diabetics in Punjabi population. Int. J. Adv. Med. 4 (4), 1026\u20131030 (2017).","journal-title":"Int. J. Adv. Med."},{"key":"79516_CR28","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.2147\/DMSO.S206053","volume":"13","author":"C Bagias","year":"2020","unstructured":"Bagias, C., Xiarchou, A., Bargiota, A. & Tigas, S. Familial partial lipodystrophy (FPLD): recent insights. Diabetes Metab. Syndr. Obes. 13, 1531\u20131544 (2020).","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"10","key":"79516_CR29","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.2337\/dc18-0978","volume":"41","author":"R Meral","year":"2018","unstructured":"Meral, R. et al. Fat shadows from DXA for the qualitative Assessment of Lipodystrophy: when a picture is Worth a Thousand numbers. Diabetes Care. 41 (10), 2255\u20132258 (2018).","journal-title":"Diabetes Care"},{"issue":"3","key":"79516_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ejendo\/lvad023","volume":"188","author":"C Gosseaume","year":"2023","unstructured":"Gosseaume, C. et al. Perinatal, metabolic, and reproductive features in PPARG-related lipodystrophy. Eur. J. Endocrinol. 188 (3), 273\u2013281 (2023).","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"79516_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11892-018-1099-9","volume":"18","author":"B Akinci","year":"2018","unstructured":"Akinci, B., Meral, R. & Oral, E. A. Phenotypic and genetic characteristics of Lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities. Curr. Diab Rep. 18 (12), 143 (2018).","journal-title":"Curr. Diab Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79516-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79516-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79516-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T09:11:27Z","timestamp":1732093887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79516-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["79516"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-79516-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4265901\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"14 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28277"}}